The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Development and Validation of the American Heart Association’s PREVENT Equations
Open accessAbstract
BACKGROUND: Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current equations have several limitations. Therefore, we developed and validated the American Heart Association Predicting Risk of CVD EVENTs (PREVENT) equations among US adults 30 to 79 years of age without known CVD. METHODS: The derivation sample included individual-level participant data from 25 data sets (N=3 281 919) between 1992 and 2017. The primary outcome was CVD (atherosclerotic CVD and heart failure). Predictors included traditional risk factors (smoking status, systolic blood pressure, cholesterol, antihypertensive or statin use, and diabetes) and estimated glomerular filtration rate. Models were sex-specific, race-free, developed on the age scale, and adjusted for competing risk of non-CVD death. Analyses were conducted in each data set and meta-analyzed. Discrimination was assessed using the Harrell C-statistic. Calibration was calculated as the slope of the observed versus predicted risk by decile. Additional equations to predict each CVD subtype (atherosclerotic CVD and heart failure) and include optional predictors (urine albumin-to-creatinine ratio and hemoglobin A1c), and social deprivation index were also developed. External validation was performed in 3 330 085 participants from 21 additional data sets. RESULTS: Among 6 612 004 adults included, mean±SD age was 53±12 years, and 56% were women. Over a mean±SD follow-up of 4.8±3.1 years, there were 211 515 incident total CVD events. The median C-statistics in external validation for CVD were 0.794 (interquartile interval, 0.763–0.809) in female and 0.757 (0.727–0.778) in male participants. The calibration slopes were 1.03 (interquartile interval, 0.81–1.16) and 0.94 (0.81–1.13) among female and male participants, respectively. Similar estimates for discrimination and calibration were observed for atherosclerotic CVD– and heart failure–specific models. The improvement in discrimination was small but statistically significant when urine albumin-to-creatinine ratio, hemoglobin A1c, and social deprivation index were added together to the base model to total CVD (ΔC-statistic [interquartile interval] 0.004 [0.004–0.005] and 0.005 [0.004–0.007] among female and male participants, respectively). Calibration improved significantly when the urine albumin-to-creatinine ratio was added to the base model among those with marked albuminuria (>300 mg/g; 1.05 [0.84–1.20] versus 1.39 [1.14–1.65]; P =0.01). CONCLUSIONS: PREVENT equations accurately and precisely predicted risk for incident CVD and CVD subtypes in a large, diverse, and contemporary sample of US adults by using routinely available clinical variables.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We have conducted sensitivity analyses by applying the American Heart Association (AHA) Predicting Risk of CVD Events (PREVENT) risk formula based on diverse population, which produced directionally consistent treatment effect.33”
From Tirzepatide compared with semaglutide and 10-year cardiovascular disease risk reduction in obesity: post-hoc analysis of the SURMOUNT-5 trial (2025) · cites this paper as [33]
In the citing paper
“The American Heart Association’s PREVENT Equations use a social deprivation index to recognize the impact that social deprivation can have on cardiovascular-kidney-metabolic conditions [96,99].”
From Bias in medical AI: Implications for clinical decision-making (2024) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citationHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Self-citationGrundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Self-citationSontrop, J. M., Dixon, S. N., Garg, A. X., Jiménez, I. B., Dohein, O., Huang, S. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,903
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Self-citationNew creatinine- and cystatin C-based equations to estimate GFR without race
Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., Crews, D. C., Doria, A., Estrella, M. M., Froissart, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102953 · Cited by 4,695
Self-citationArnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
Self-citation(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,000
Hamel‐Sellman, D. J., Prescott, B. R., Korzinski, T. J., Xanthakis, V., Cooper, L. L., Hamburg, N. M., Tsao, C. W., Benjamin, E. J., Vasan, R. S., & Mitchell, G. F. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.044872
Lipoprotein(a) Elevation for Refining Risk Stratification With the PREVENT Equations
Mangalesh, S., & Nanna, M. G. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.4450
Serum Metabolites and Heart Failure Risk: MESA and RS
Zhu, F., Sinha, A., Graça, G., Neeland, I. J., Pandey, A., Tzoulaki, I., Karaman, İ., Tracy, R. P., Lima, J. A. C., Shah, S. J., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.044211 · Cited by 1
Self-citationLiang, J., Li, H., Zhong, Y., Li, P., Huang, Z., Wang, D., & Wen, J. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01187-5
External Validation of the 2023 Australian Cardiovascular Risk Calculator
Barwick, G., Hancock, S. J., Ren, S. P., Hure, A. J., & Attia, J. (2025) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.08.029
Peng, N., Li, P., & Liu, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-27975-x · Cited by 1
Editorial: Measuring what matters: Integrating coronary severity and ischemia to predict outcomes
Verma, B. R., & Case, B. C. (2025) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2025.12.014
Dean, M. R., Bane, B. L., Aluko, O., Hang, Y., Miller, E., Menachery, S. M., Chuquin, D., Aston, A., Deng, X., Bandyopadhyay, D., et al. (2025) · Cancers · doi:10.3390/cancers18010012
Cardiovascular–Kidney–Metabolic Syndrome: Untangling the Interconnected Burden
Anupama, Y. J. (2025) · Indian Journal of Kidney Diseases · doi:10.4103/ijkd.ijkd_35_25
Qin, Y., & Gou, L. (2025) · medRxiv · doi:10.64898/2025.12.10.25342023
Kunhiraman, H. H., Kruse‐Diehr, A. J., Koo, P. J., Barata, P. C., Patel, S. A., Armstrong, A. J., Swami, U., Morgans, A. K., Alumkal, J. J., Hahn, A. W., et al. (2025) · medRxiv · doi:10.64898/2025.12.18.25342579
Comparison of European vs American High Blood Pressure Guidelines—A Transoceanic Journey
Grassi, G. M. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm47412
The cardiovascular evaluation of candidates for living kidney donation
Chauhan, K., Garg, N., Wolff, M. R., Mandelbrot, D. A., & Dhingra, R. (2026) · Transplantation Reviews · doi:10.1016/j.trre.2025.100990
Zhang, Z., Wang, C., Zhou, X., Lu, J., Chen, B., Wu, M. C., Zhang, X., Yang, Y., Cui, J., Xu, W., et al. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag012
Prevalence of statin utilization in cancer survivors in a family medicine clinic
White, R. T., Cornelio, C. K., Tsalatsanis, A., Hanna, K., Maru, J., Vial, E., & Carris, N. W. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-025-10295-1
Shakil, S. S., Grogan, T., So‐Armah, K., Ganz, P., Freiberg, M. S., & Hsue, P. Y. (2026) · medRxiv · doi:10.64898/2026.01.08.25343149
Cracks in the Great Wall: Acute MI Beyond Traditional Risks in Chinese Patients
Anderson, J. L. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.125.012877
Alcantara, M., Shapiro, G. D., Platt, R. W., Abrahamowicz, M., Ray, J. G., Ukah, U. V., & Dayan, N. (2026) · JACC Advances · doi:10.1016/j.jacadv.2025.102511
Yang, H., & Lu, Y. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101428
Sex-Specific Blood Pressure Thresholds in Middle-Aged Adults
Williams, K., Grobman, B., Kwapong, F. L., Col, H., Turkson‐Ocran, R., Ngo, L. H., Zhang, M., Daya, N. R., Selvin, E., Lutsey, P. L., et al. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.25490
Self-citationHaenel, A., Jukema, R., Khoo, J. K., Coughlan, F., Blanke, P., Ferkh, A., Fairbairn, T. A., Ng, N., Koweek, L., Douglas, P. S., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120515
Grant, J. K., Selvam, P. V., Koester, M., Leucker, T. M., & Barth, A. S. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.10.002
Xi, Y., Wang, Q., & Zhu, B. (2026) · medRxiv · doi:10.64898/2026.01.13.26344014
Aihaiti, A., Abulajiang, S., Tuerxun, H., Li, N., & Nijiati, M. (2026) · European journal of medical research · doi:10.1186/s40001-025-03713-x
Wong, N. D., Karthikeyan, H., Fan, W., & Electricwala, B. (2026) · JACC Advances · doi:10.1016/j.jacadv.2025.102517
Scott, C. A., Li, L., & Rothwell, P. M. (2026) · BMC Medicine · doi:10.1186/s12916-026-04657-7
The Intersection of Heart Failure with Preserved Ejection Fraction and CKD
Krishnan, V., Khan, S. S., & Mehta, R. C. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001013
Self-citationBi, X., He, Y. Y., Shen, Y., Shen, Y., Shen, A., Zhou, S., Li, X., Ding, F., Nie, S., & Wang, W. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2617718
Stjernholm, K., Andersen, H. S., Jensen, A. E., & Nielsen, J. B. (2026) · Open Heart · doi:10.1136/openhrt-2025-003812
Yuan, M., Li, L., Hou, Y., Wei, L., Zhang, R., & Jiang, H. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s576278
李, 霄. (2026) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2026.51084
Naghavi, M., Mirjalili, S. R., Atlas, K. C., Reeves, A. P., Zhang, C., Wasserthal, J., Azimi, A., Hashemi, A., MozafaryBazargany, M., Atlas, T. L., et al. (2026) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeag027
Barzilay, J. I., Trujillo, R., Hansen, S. L., Blaha, M. J., Budoff, M. J., & McClelland, R. L. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.043845
Self-citationTian, Z., Sternberg, M., Willerding, J. M., Schmidt-Ott, K. M., Melk, A., & Schmidt, B. (2026) · medRxiv · doi:10.64898/2026.01.28.26345070
Statin Eligibility Disparities with Transition from the Pooled Cohort Equations to the AHA PREVENTPreprint
Yan, X., Huang, Q., Li, J., Husby, H. M., Jose, P. O., Kenkare, P., Solomon, M. D., Rodríguez, F., & Bacong, A. M. (2026) · medRxiv · doi:10.64898/2026.01.29.26345173
Gurevitz, C., Fisher, R. E., Muntner, P., Sagendorf, T. J., Fisher, E. A., & Rosenson, R. S. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101462
Liu, X., Wu, S., Zhang, H., & Xue, F. (2026) · Archives of Public Health · doi:10.1186/s13690-026-01846-x
Zhao, L., & Gao, Q. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104610 · Cited by 1
Long-term risk assessment in primary prevention: making the case for 30-year PREVENT scores
Allen, T., Bhatia, H. S., & Allison, M. A. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag062
Preventive Care, Screening, and Health Care Maintenance for Transgender Populations
Zucker, S. M., Mayer, G. M., Ran, D., Muckler, J., & Siegel, J. R. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2025.12.005
‘U’r-in(e)!—urine albumin-creatinine ratio: the old kid on a new block!
Bene-Alhasan, Y. O., Nambi, V., & Ballantyne, C. M. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag083
Zhang, X., Chen, D., Wu, L., Zhuang, Y., Yang, J., Wang, Y., Li, Y., Zhang, Q., & Zhao, J. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101470
Primary Prevention in Older Adults
Parsons, B., Soni, S., Rao, S., & Mehta, A. (2026) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2025.12.010
Scheuermann, B. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.56865
Validating clinical risk scores in contemporary populations using CCTA
Cainzos‐Achirica, M. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101483
Risk scoring for the primary prevention of cardiovascular disease
Hernández, A. V., Diaz‐Arocutipa, C., Valenzuela-Rodríguez, G., Feigin, V. L., Banda, S., Barboza, J. J., Mayta‐Tovalino, F., Virú-Loza, M. A., Persell, S. D., Wafford, Q. E., et al. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016333
Self-citationCardiovascular Risk Prediction in Breast Cancer Survivors
Sierra-Pagán, J. E., & Levin, M. G. (2026) · JACC CardioOncology · doi:10.1016/j.jaccao.2025.12.001
Garcon, J., Lavigne‐Robichaud, M., Milot, A., Talbot, D., Gilbert‐Ouimet, M., Brisson, C., Dionne, C. E., & Trudel, X. (2026) · CJC Open · doi:10.1016/j.cjco.2026.01.014
Solomon, D. H., Santacroce, L. M., Giles, J. T., Rist, P. M., Everett, B. M., Liao, K. P., Paudel, M. L., Shadick, N. A., Weinblatt, M. E., Bathon, J., et al. (2026) · medRxiv · doi:10.64898/2026.02.18.26346592
Lai, W., Xiao, L., He, J., Huang, Z., He, J., & Gu, W. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01096-2
Evaluation and Management of Hypertension in Older Adults
Petriceks, A. H., Berlot, A., Mason, T., Marion, W., Corbett, C., & Juraschek, S. P. (2026) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2025.12.004
Jeon‐Slaughter, H., Whyne, E. Z., Doyle, C., Chen, X., Chiou, S. H., Tsai, S. X., & Ebrahimi, R. (2026) · JACC Asia · doi:10.1016/j.jacasi.2026.01.003
Bakhshi, B., Lin, H., Sultana, N., Healey, E., Queen, H., Claudel, S. E., Minetti, E. T., Mitchell, G. F., Murabito, J. M., Lloyd‐Jones, D. M., et al. (2026) · medRxiv · doi:10.64898/2026.02.25.26347035
Self-citationWang, Y., Huang, A., Bi, L., Li, S., Li, Q. Y., Zhang, P., & Lv, T. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm45493
Brandt, E. J., & Bauer, K. W. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.01.070
Sirota, S., Allen, N. B., Barr, R. G., & Malinsky, D. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045048
From Segmentation to MACE Prediction
Miller, R. J. H., & Bertelli, M. (2026) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2026.02.001
Berg, D. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00008-2
Prevalence and mortality of cardiovascular-kidney-metabolic syndrome in US adults, 1999–2018
Cheema, H. A., Shahid, A., Rahman, S. U., Nasir, K., Patel, J., Kulkarni, A., Rangaswami, J., Ganatra, S., & Dani, S. S. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.100742
Self-citationGale, C. P., Bhutani, M., Chan, J. S. K., Townend, J., Patel, M., Sadatsafavi, M., Henley, W., Ariti, C. A., Carter, V. A., Couper, A., et al. (2026) · Pragmatic and Observational Research · doi:10.2147/por.s551291
Ovarian reserve and endothelial health in healthy reproductive-age women
Wang, A., Bleil, M. E., Rosen, M. P., Redberg, R., Lin, J., Smith, D. L., McCulloch, C. E., & Cedars, M. I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag105
Manghis, E. M., Chang, R. S.-W., Feng, L., Gadgil, M. D., Shah, N. S., Budoff, M. J., & Kanaya, A. M. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101538
Rathore, M., Khokhar, M., Kumar, S., Gopalakrishnan, M., Sankanagoudar, S., Banerjee, M., Sharma, P., & Tomo, S. (2026) · Laboratory Medicine · doi:10.1093/labmed/lmag003
Explainable Federated Cardiovascular Risk with Compact MLPs
Sikder, A. H., Hridoy, M. S. R., Arman, M. A. A., Ali, M. A., & Mamun, M. A. A. (2026) · International Conference on Electrical, Computer & Telecommunication Engineering (ICECTE) · doi:10.1109/icecte69292.2026.11429398
Comorbidity indices in observational studies on cardiovascular risk
Zethelius, B., Talbäck, M., & Ljung, R. (2026) · Open Heart · doi:10.1136/openhrt-2026-003999
Pavlovich, R., Cushman, M., Judd, S. E., Howard, V. J., Safford, M. M., Bullen, A. L., & Wettersten, N. W. (2026) · American Journal of Nephrology · doi:10.1159/000549907
Ren, P., Guo, Y., & Zhao, L. (2026) · Scientific Reports · doi:10.1038/s41598-026-44165-5 · Cited by 1
From coronary calcium to heart failure risk: Expanding the role of CT in preventive cardiology
Al-Kindi, S. G., & Patel, K. V. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101555
Eşki, S., Taşkan, H., Eravcı, Ö., Karaca, Ş., Arslan, A., & Yıldırım, E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062346
Chang, R. P., Redman, L. M., Ravussin, É., Apovian, C. M., & Ostrominski, J. W. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70684
Masrouri, S., Ebrahimi, N., Hasanpour, A., Sohrabi, B., Azizi, F., & Hadaegh, F. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113223
Management of Hypertension in Adults
Johnson, A. E., Jackson, C. D., & Alexander, J. T. (2026) · JAMA · doi:10.1001/jama.2026.1132 · Cited by 1
Visceral adiposity and cardiovascular risk in the era of cardiovascular-kidney-metabolic syndrome
Kokkorakis, M., & Oikonomou, E. K. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101558
Gästgivars, O., Wiklund, U., & Brunström, M. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004301
PREVENTing Undertreatment of Modifiable Risk in Young Adults
Lee, H., & Návar, A. M. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.02.5065
Nam, D., Seo, J., Jang, M., Thakur, S., Nusinovici, S., Park, T. H., Yoo, T. K., Rim, T. H., Bakhai, A., Papadopoulou, S., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8774970/v1
Self-citationMultidimensional nomogram for prediction of cardiovascular disease risk in cancer survivors
Ding, X.-R., Yao, J., Fei, Y., Tang, J.-Y., Ye, X. M., Zhou, T.-H., & Xu, H.-P. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10598-x
Karayakalı, M., Kadi, H., Karaman, K., Çelik, A., Özbek, K., Damar, İ. H., Zorlu, Ç., Atmaca, H., Ömür, S. E., & Önalan, O. (2026) · Angiology · doi:10.1177/00033197261435386
Yatsuya, H., & Horikoshi, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00186-2
Meche, A., Boonyasai, R. T., Hsu, Y., Greer, R. C., Mehta, H., Alexander, G. C., Segal, J. B., Cooper, L. A., & Jackson, J. W. (2026) · Epidemiology · doi:10.1097/ede.0000000000001964
Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US—Reply
Khan, S. S., Ndumele, C. E., & Lloyd‐Jones, D. M. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.0412
Self-citationElevated LDL-C and non–HDL-C in U.S. adults with normal total serum cholesterol
Essa, M., Zhang, Z., Martin, S. S., Michos, E. D., Jones, S. R., Spatz, E. S., Blumenthal, R. S., & Faridi, K. F. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.03.023
Epidemiology of Atherosclerotic Cardiovascular Disease
Penz, C. S., & Lieb, W. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00084-4
Gaps in lipid screening and statin use among uninsured patients in a charitable community clinic
Ingle, T. A., Tran, C., Pannell, M., Hurt, M., Peedikayil, J., Umaña, L. J., Gimpel, N. E., Khera, A., & Ahmad, Z. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101603
He, Z., Xiong, W., Li, Y., Wu, X., Zhang, Y., Shan, X., Liu, Y., & Rang, W. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.100779
Lipids and Cardiovascular Diseases: Epidemiologic Perspectives
Nguyen, X.-M. T., Wilson, P. W. F., Okamura, T., Sugiyama, D., Hirata, T., Kuwabara, K., & Hirata, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00066-2
Obesity and Cardiovascular Disease
Kenchaiah, S., & Matsushita, Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00073-x
Fuentes-Yufra, A., Ingar-Choque, L. F., Franco-Espinoza, A. E., Miranda-Chávez, B., Inquilla-Castillo, M. A., & Corzo, C. A. C. (2026) · Revista de la Facultad de Medicina Humana · doi:10.25176/rfmh.v26i1.7715
Traditional and Emerging Lipid Markers for Cardiovascular Risk Assessment in Young vs Older Adults
Tang, R., An, J., Bellows, B. K., Moran, A. E., Allen, N. B., Wilkins, J. T., Xanthakis, V., Tsai, M. Y., Shah, N. S., Reynolds, K., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.5199
Vascular age: a tool to facilitate communication with patients about cardiovascular risk
Brotons, C., & Moral, I. (2026) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2026.500936
Expanded Lipid Biomarkers and Estimating Risk Beyond PREVENT
Davis, J. W., & Manson, J. E. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.5207
Green, C. A., Earls, B., Jochum, M., Jelovsek, J. E., Venkatesh, K. K., Adams, A. D., & Williams, D. (2026) · Pregnancy · doi:10.1002/pmf2.70288
Kim, B., Jeon, M., Lee, Y., Reem, H., & Chung, S. M. (2026) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2026.43.28
Shitole, S. G., Chen, E., Naveed, M., Xue, X., Sharma, A., Hanna, D. B., Anastos, K., Kaplan, R. C., Levsky, J. M., Tien, P. C., et al. (2026) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003808
Lan, J., Liu, M., Wang, Y., Feng, J., & Wang, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9035595/v1
Kastrati, L., Alexandri, E. M., Rupp, M. E., Koch, L. M., Garcia‐Tirado, J., Nakas, C. T., Maron, D. J., Herzig, D., & Bally, L. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101625
What is the Best Cardiovascular Risk Score in Our Daily Practice?
de Oliveira, G. M. M. (2026) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20250282
Metadata
- Authors
- Khan, S. S., Matsushita, K., Sang, Y., Ballew, S. H., Grams, M. E., Surapaneni, A., Blaha, M. J., Carson, A. P., Chang, A. R., Ciemins, E., Go, A. S., Gutierrez, O. M., Hwang, S.-J., Jassal, S. K., Kovesdy, C. P., Lloyd-Jones, D. M., Shlipak, M. G., Palaniappan, L. P., Sperling, L., Virani, S. S., Tuttle, K., Neeland, I. J., Chow, S. L., Rangaswami, J., Pencina, M. J., Ndumele, C. E., Coresh, J., & for the Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group
- Affiliations
- Northwestern University (US)
- Johns Hopkins University (US)
- New York University (US)
- University of Mississippi Medical Center (US)
- Departments of Nephrology and Population Health Sciences, Geisinger Health, Danville, PA (A.R.C.).
- American Medical Group Association (US)
- Kaiser Permanente (US)
- Departments of Epidemiology and Medicine, University of Alabama at Birmingham (O.M.G.).
- National Heart, Lung, and Blood Institute (US)
- University of California San Diego (US)
- University of Tennessee Health Science Center (US)
- Department of Preventive Medicine, Northwestern University, Chicago, IL (D.M.L.-J.).
- San Francisco VA Medical Center (US)
- Stanford Medicine (US)
- Emory University (US)
- Aga Khan University (PK)
- University of Washington (US)
- University Hospitals of Cleveland (US)
- Western University of Health Sciences (US)
- George Washington University (US)
- Duke University (US)
- ORCID
- Khan, Sadiya S.
- Matsushita, Kunihiro
- Sang, Yingying
- Ballew, Shoshana H.
- Grams, Morgan E.
- Surapaneni, Aditya
- Blaha, Michael J.
- Carson, April P.
- Chang, Alexander R.
- Ciemins, Elizabeth
- Go, Alan S.
- Gutierrez, Orlando M.
- Hwang, Shih-Jen
- Jassal, Simerjot K.
- Kovesdy, Csaba P.
- Lloyd-Jones, Donald M.
- Shlipak, Michael G.
- Palaniappan, Latha P.
- Sperling, Laurence
- Virani, Salim S.
- Tuttle, Katherine
- Neeland, Ian J.
- Chow, Sheryl L.
- Rangaswami, Janani
- Pencina, Michael J.
- Ndumele, Chiadi E.
- Coresh, Josef
- Venue
- Circulation
- Published
- 2024-02-06
- Volume
- 149
- Issue
- 6
- Pages
- 430-449
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC10910659
- OpenAlex
- W4388573970
- Cited by
- 1,234
- References
- 92
- Citations by year
- 2026: 631 · 2025: 467 · 2024: 134
- FWCI
- 314.97
- Type
- journal article
- Language
- en
- Update notices
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- eCommons - AKU (Aga Khan University) (submittedVersion)
- Funders
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100446)
- HHS | NIH | National Heart, Lung, and Blood Institute (R21HL165376)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- PREVENT equations, cardiovascular risk prediction, absolute cardiovascular risk, atherosclerotic cardiovascular disease, heart failure, albumin-creatinine ratio, estimated glomerular filtration rate, social deprivation index, HbA1c, risk discrimination and calibration
- MeSH terms
- Adult, Aged, Albumins, American Heart Association, Cardiovascular Diseases, Creatinine, Female, Heart Failure, Glycated Hemoglobin, Humans, Male, Middle Aged, Risk Factors, Risk Assessment, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
